Form 8K Issued June 4, 2014

From May 25 to May 28, 2014, Dr. Dick Zoutman, a consultant to Medizone International, Inc. (the “Company”) presented information regarding the Company’s AsepticSure ® hospital disinfection system at the IPAC Canada 2014 National Education Conference in Halifax, Nova Scotia, Canada.




As part of Dr. Zoutman’s presentation, he included a poster entitled the “Positive Impacts of a New Ozone and Hydrogen Peroxide Vapour System to Disinfect Patient Rooms During an MRSA Outbreak” to describe the Company’s development of the AsepticSure system and more particularly the use of the system in eliminating the transmission of MRSA in a 20-bed facility in Canada in June 2013.

Attached to this report as Exhibit 99.1 is a copy of the poster, which will be posted on or about June 3, 2014 on the Company’s website,


In accordance with General Instruction B.2. of Form 8-K, the information contained above in this Item 7.01 (including the poster) shall not be deemed “Filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall the Investor Presentation be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing. This Item 7.01 will not be deemed a determination or an admission as to the materiality of any information in this Item 7.01 that is required to be disclosed solely by Regulation FD.

Medizone International, Inc. (OTCQB: MZEI)

350 East Michigan Avenue – Suite 500
Kalamazoo, MI 49007

Telephone: (269) 202-5020

Email: [email protected]

Media and Investor Relations:

John Pentony

Medizone International, Inc.

Telephone: (269) 202-5020

Email: [email protected]

Social Media